Clinical Pharmacology & Therapeutics · 1996 · 71 citations · 32 references
PharmacyClinical PharmacokineticsPharmacologyDementiaGeriatric PharmacokineticsGeriatric PharmacologyDementia PharmacotherapyMultiple-dose PharmacokineticsNeurodegenerative Disease PharmacotherapyPharmacokinetics In DementiaAlzheimer's Disease PharmacokineticsDrug Distribution In DementiaMultiple-dose InfusionOptimal Dose SelectionPharmacokinetics In Neurodegenerative DiseasePharmacological Treatment Of DementiaPlasma Half-life Extension
OBJECTIVE: To study the pharmacokinetics and pharmacodynamics of intravenously administered arecoline in subjects with Alzheimer's disease. METHODS: Plasma arecoline concentrations were measured during and after high-dose (i.e., 5 mg intravenously over 30 minutes) and up to 2 weeks of continuous multiple-dose steady-state intravenous infusions of arecoline in 15 subjects with mild to moderate Alzheimer's disease. During multiple-dose infusions, the dose of arecoline was escalated from 0.5 to 40 mg/day. Psychometric tests were administered at baseline and every other dose to determine an "optimal dose" for each subject. This dose then was administered for 1 week using a randomized, placebo-controlled, double blind, crossover design. Plasma drug concentrations were measured by GC-MS. RESULTS: The optimal dose of arecoline varied fourfold across subjects (4 mg/day, n = 6; 16 mg/day, n = 3) with mean plasma half-lives of 0.95 +/- 0.54 and 9.3 +/- 4.5 (SD) minutes. Clearance and volume of distribution were 13.6 +/- 5.8 L/min and 205 +/- 170 (SD) L, respectively. At the dose that optimized memory, the mean plasma level was 0.31 +/- 0.14 (SD) ng/ml, and it predicted the optimal dose in all subjects. CONCLUSIONS: Because optimal dose variation is due to differing plasma kinetics, the plasma arecoline level measured at a single infusion rate can be used to choose the optimal dose for memory enhancement in patients with Alzheimer's disease.
32
Clinical diagnosis of Alzheimer's disease
Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 28K citations · Full text
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
PJ Whitehouse, DL Price, R. G. Struble et al. · Science · 1982 · 3.6K citations
Human Memory and the Cholinergic System
David A. Drachman · Archives of Neurology · 1974 · 1.4K citations
Medicine, Neuroscience, Pharmacology +17